Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
TACTICAL: TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
The purpose of this study is to test the feasibility and safety of early cessation of tacrolimus following allogeneic hematopoietic cell transplantation (HCT).…
GVHDHematopoietic Cell Transplantation (HCT)Acute Myeloid Leukemia (AML)+4 more
Estimated
~$10 – $6,250
Stanford UniversityNCT07302776
Phase 1
A Phase I Study to Evaluate the Safety and Maximum Tolerated Dose of Momelotinib Durind and Following Hematopoietic Cell Transplantation for Patients With Myelofibrosis
This is a single-center, open-label, phase I study to determine the safety and tolerability of momelotinib in patients with myelofibrosis during and after hema…
MyelofibrosisHematopoietic Cell Transplantation (HCT)
Estimated
~$10 – $6,250
Massachusetts General HospitalNCT07104799